Choksi Laboratories Ltd. | Small-cap | Healthcare
₹184.05
4.25%
| Choksi Laboratories Stock Comparison:
Choksi Laboratories vs Dr. Lal PathLabsChoksi Laboratories vs SyngeneChoksi Laboratories vs Vimta LabsChoksi Laboratories vs Krsnaa DiagnosticsChoksi Laboratories vs Suraksha DiagnosticChoksi Laboratories vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 112.4M
Gross Profit 92.7M 82.45%
Operating Income 12.3M 10.93%
Net Income 3.8M 3.42%
EPS (Diluted) ₹0.55

Balance Sheet Metrics

Total Assets 653.3M
Total Liabilities 417.3M
Shareholders Equity 236.0M
Debt to Equity 1.77

Cash Flow Metrics

Revenue & Profitability Trend

Choksi Laboratories Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i417.8M367.0M344.4M300.4M256.9M
Cost of Goods Sold i46.2M37.2M33.8M28.3M35.1M
Gross Profit i371.6M329.7M310.6M272.1M221.8M
Gross Margin % i88.9%89.9%90.2%90.6%86.3%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i12.6M11.6M11.1M7.8M7.8M
Other Operating Expenses i68.7M63.2M56.9M50.3M51.1M
Total Operating Expenses i81.3M74.8M68.1M58.0M59.0M
Operating Income i50.1M47.2M49.5M36.6M-3.0M
Operating Margin % i12.0%12.9%14.4%12.2%-1.2%
Non-Operating Items
Interest Income i598.0K1.6M2.0M1.2M4.4M
Interest Expense i26.6M30.1M34.9M32.1M28.0M
Other Non-Operating Income-----
Pre-tax Income i21.5M16.6M37.2M3.7M-28.1M
Income Tax i6.3M5.5M5.1M1.6M-2.0M
Effective Tax Rate % i29.3%33.3%13.7%43.6%0.0%
Net Income i15.2M11.1M32.1M2.1M-26.1M
Net Margin % i3.6%3.0%9.3%0.7%-10.2%
Key Metrics
EBITDA i115.1M105.4M106.4M91.8M47.0M
EPS (Basic) i₹2.19₹1.59₹4.61₹0.30₹-3.74
EPS (Diluted) i₹2.19₹1.59₹4.61₹0.30₹-3.74
Basic Shares Outstanding i69650006965000696500069650006965000
Diluted Shares Outstanding i69650006965000696500069650006965000

Income Statement Trend

Choksi Laboratories Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i6.1M6.6M3.4M4.1M3.1M
Short-term Investments i1.2M4.3M4.2M662.0K576.0K
Accounts Receivable i112.7M103.9M106.5M102.9M81.6M
Inventory i5.6M3.6M2.1M2.5M1.1M
Other Current Assets1.0K1.0K6.2M-1.0K-1.0K
Total Current Assets i163.2M145.7M139.5M140.1M130.3M
Non-Current Assets
Property, Plant & Equipment i471.3M36.1M36.1M36.1M36.1M
Goodwill i4.8M3.6M3.9M3.2M2.9M
Intangible Assets i4.8M3.6M3.9M3.2M2.9M
Long-term Investments000--
Other Non-Current Assets141.0K2.0K1.0K909.0K2
Total Non-Current Assets i490.1M473.8M464.2M504.1M533.5M
Total Assets i653.3M619.5M603.6M644.2M663.8M
Liabilities
Current Liabilities
Accounts Payable i54.3M39.3M18.0M40.2M48.3M
Short-term Debt i131.9M117.9M72.0M76.9M78.0M
Current Portion of Long-term Debt-----
Other Current Liabilities664.0K706.0K867.0K1.6M436.0K
Total Current Liabilities i238.8M188.5M125.1M155.2M162.2M
Non-Current Liabilities
Long-term Debt i159.6M190.8M252.1M296.0M313.5M
Deferred Tax Liabilities i00000
Other Non-Current Liabilities-1.0K-1.0K-1.0K--
Total Non-Current Liabilities i178.5M208.9M267.4M309.9M324.1M
Total Liabilities i417.3M397.4M392.6M465.1M486.3M
Equity
Common Stock i69.7M69.7M69.7M69.7M69.7M
Retained Earnings i150.6M135.3M124.2M92.2M90.1M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i236.0M222.1M211.1M179.0M177.5M
Key Metrics
Total Debt i291.6M308.7M324.2M372.9M391.5M
Working Capital i-75.5M-42.8M14.3M-15.1M-31.9M

Balance Sheet Composition

Choksi Laboratories Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i21.5M16.6M37.2M3.7M-28.1M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i3.9M-8.4M-12.5M-18.0M-4.0M
Operating Cash Flow i51.4M36.6M35.0M16.6M-8.8M
Investing Activities
Capital Expenditures i-74.4M-69.1M-7.1M-26.4M-80.5M
Acquisitions i-----
Investment Purchases i-----
Investment Sales i197.0K1.9M52.0K--
Investing Cash Flow i-74.2M-67.2M-7.0M-26.4M-80.5M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i38.4M310.1M20.0M26.7M47.3M
Debt Repayment i-58.7M-363.7M-55.1M-41.3M-11.2M
Financing Cash Flow i-10.5M-11.1M-36.6M-14.5M36.1M
Free Cash Flow i40.9M44.6M41.0M50.1M-22.0M
Net Change in Cash i-33.3M-41.8M-8.6M-24.3M-53.2M

Cash Flow Trend

Choksi Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 84.11
Price to Book 5.32
Price to Sales 2.96
PEG Ratio -10.09

Profitability Ratios

Profit Margin 3.52%
Operating Margin 10.90%
Return on Equity 6.45%
Return on Assets 2.33%

Financial Health

Current Ratio 0.68
Debt to Equity 123.52
Beta 0.08

Per Share Data

EPS (TTM) ₹2.14
Book Value per Share ₹33.82
Revenue per Share ₹60.82

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
choksila1.3B84.115.326.45%3.52%123.52
Dr. Lal PathLabs 270.6B50.7612.0022.08%20.29%7.14
Syngene 254.9B50.135.3610.50%13.61%12.23
Vimta Labs 34.7B46.528.6917.78%19.93%2.25
Krsnaa Diagnostics 25.3B31.162.788.79%10.84%23.06
Suraksha Diagnostic 15.7B46.747.3815.14%12.62%42.28

Financial data is updated regularly. All figures are in the company's reporting currency.